✦ LIBER ✦

Comparative study of polymorphism frequencies of the CYP2D6 , CYP3A5 , CYP2C8 and IL-10 genes in Mexican and Spanish women with breast cancer

✍ Scribed by Alcazar-González, Gregorio Antonio; Calderón-Garcidueñas, Ana Laura; Garza-Rodríguez, María Lourdes; Rubio-Hernández, Gabriela; Escorza-Treviño, Sergio; Olano-Martin, Estibaliz; Cerda-Flores, Ricardo Martín; Castruita-Avila, Ana Lilia; González-Guerrero, Juan Francisco; le Brun, Stéphane; Simon-Buela, Laureano; Barrera-Saldaña, Hugo Alberto

Book ID: 124055542
Publisher: Future Medicine
Year: 2013
Tongue: English
Weight: 922 KB
Volume: 14
Category: Article
ISSN: 1462-2416
DOI: 10.2217/pgs.13.83

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic polymorphisms of drug-metabolizi

Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population

✍ Kostas Arvanitidis; Georgia Ragia; Maria Iordanidou; Sofia Kyriaki; Athanasia Xa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

Allele and genotype frequencies of the p

Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1,CYP3A4, CYP3A5, CYP2C9andCYP2C19) in the Jordanian population

✍ Al-Motassem Yousef, Nailya R. Bulatova, William Newman… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 273 KB

Role of genetic polymorphisms of CYP1A1,

Role of genetic polymorphisms of CYP1A1, CYP3A5, CYP2C9, CYP2D6, and PON1 in the modulation of DNA damage in workers occupationally exposed to organophosphate pesticides

✍ Satyender Singh; Vivek Kumar; Kapil Vashisht; Priyanka Singh; Basu Dev Banerjee; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Genetic polymorphisms of CYP2D6*10 and C

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

✍ Matthew Goetz; Vera Suman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

The study by Okishiro et al 1 concludes that the cytochrome P450 (CYP) genotype CYP2D6\*10/\*10 is unlikely to have a clinically significant impact on prognosis in women with breast cancer who receive adjuvant tamoxifen. However, several aspects of the study by Okishiro et al call their conclusions

Genetic polymorphisms of CYP2D6*10 and C

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2,*3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

✍ Masatsugu Okishiro; Tetsuya Taguchi; Seung Jin Kim; Kenzo Shimazu; Yasuhiro Tama 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB 👁 1 views

553 The influence of CYP2D6 and CYP3A5 p

553 The influence of CYP2D6 and CYP3A5 pharmacogenetics on pharmacokinetics of tamoxifen and its metabolites in Asian breast cancer patients

✍ B. Chowbay; J.S.L. Lim; O. Singh; R.C.H. Ng; N.S. Wong; E.J.D. Lee 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB